Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021240481 - A COMPOSITION FOR MANAGEMENT OF COVID-19 AND ASSOCIATED DISORDERS

Publication Number WO/2021/240481
Publication Date 02.12.2021
International Application No. PCT/IB2021/054727
International Filing Date 29.05.2021
IPC
A61K 36/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 31/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
CPC
A61K 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
12Ketones
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/4525
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
445Non condensed piperidines, e.g. piperocaine
4523containing further heterocyclic ring systems
4525containing a five-membered ring with oxygen as a ring hetero atom
A61K 31/7048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin ; digitoxin or digoxin
A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
Applicants
  • VEDICINALS INDIA PRIVATE LIMITED [IN]/[IN]
Inventors
  • SALUNKE, Prakash Pundlik
  • SALUNKE, Vaisahli Prakash
  • PATIL, Pravin Ekanath
Agents
  • KHURANA & KHURANA, ADVOCATES & IP ATTORNEYS
Priority Data
20202102263829.05.2020IN
20212101793319.04.2021IN
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) A COMPOSITION FOR MANAGEMENT OF COVID-19 AND ASSOCIATED DISORDERS
(FR) COMPOSITION POUR LA GESTION DE LA COVID-19 ET DE TROUBLES ASSOCIÉS
Abstract
(EN) The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.
(FR) La présente invention concerne une composition qui peut trouver une utilité dans la gestion de la COVID-19. Les inventeurs de la présente invention ont observé de manière surprenante que les ingrédients de la composition de la présente invention présentent une synergie fonctionnelle entre eux, la composition empêchant la réplication du virus et/ou l'entrée du virus dans des cellules humaines, soit en totalité, soit en partie, tout en modulant la réponse immunitaire du patient. Par conséquent, la composition de la présente invention a un potentiel pour une utilisation étendue dans la gestion de la COVID-19, soit seule soit en combinaison avec d'autres stratégies préventives ou palliatives/thérapeutiques.
Latest bibliographic data on file with the International Bureau